Displaying 13 - 22 items out of 22 results
ILCN article
Gender Disparity in Lung Cancer
… 2 Jyoti Patel, MD For example, germline mutations in tumor suppressor genes such as TP53, DNA repair pathway genes such as BRCA1, BRCA2, and … these emerging survival patterns, including differences in tumor biology discussed above as well as treatment response …
Press release
… laboratory projects focus on the clonal evolution of tumors, cell-free plasma DNA as biomarkers for early detection, and the role of …
Landing page
… non-small cell lung cancer (NSCLC). Her pioneering work on DNA damage response (DDR) pathways and immune activation … Multiple Myeloma program, a Lymphoma Program, a functional tumor registry, an Integrated Breast & Cervical Cancer … work on non-invasive molecular subtyping of NSCLC based on circulating tumor DNA established the foundation for liquid …
Press release
… biology and its evolution over time, using tools like circulating tumour DNA from liquid biopsies, to match patients to the adjuvant … a targeted therapy,” she stated. “The possibility to study circulating tumour cells from blood samples has been a …
Landing page
… liquid biopsies, specifically in extracellular vesicles and circulating free tumor DNA. Dr. Rolfo has authored more than 250 scientific …
Landing page
… of lung cancers harboring mutations in genes involved in DNA damage repair (DDR) derive improved clinical … of the interaction of metabolite-miRNA in driving tumor initiation. Read Spotlight Grant Recipient Hua Zhang, …
ILCN article
Debaters Argue Merits of Surgery in Malignant Meso in Light of MARS2 Data
… of surgery in the treatment of malignant mesothelioma began circulating. And after a debate at the 2024 Targeted … mesothelioma is maximal cytoreduction to remove all visible tumor, but an R0 resection is not possible. Surgery alone is …
Press release
… Award to Gabriella Sozzi, PhD. Dr. Sozzi leads the Tumor Genomics Unit at Fondazione IRCCS Istituto Nazionale Tumori (INT) in Milan, Italy. She graduated in Biological … of lung cancer in screening programs. In the field of circulating biomarkers, she has a demonstrated record of …
Landing page
… the establishment and characterization of patient-derived tumor models for lung cancer. Dr. Tsao is Chair of the … for localized mutant non-small cell lung cancer and ctDNA-guided personalized treatment. Recent relevant …
Landing page
… JTO Articles Image 159P Optimization and validation of a circulating microRNA biomarker panel for early detection of … the proportion of lung cancer in... Read More Image Tumor Microenvironment Landscape of NSCLC Reveals Resistance … and metastatic NSCLC with programmed death-ligand 1 (PD-L1) tumor... Read More Pre-Order Your Copy of the 50th …